Literature DB >> 20458058

Spectral clustering of microarray data elucidates the roles of microenvironment remodeling and immune responses in survival of head and neck squamous cell carcinoma.

Johanna K Thurlow1, Claudia L Peña Murillo, Keith D Hunter, Francesca M Buffa, Shalini Patiar, Guy Betts, Catharine M L West, Adrian L Harris, Eric K Parkinson, Paul R Harrison, Bradford W Ozanne, Max Partridge, Gabriela Kalna.   

Abstract

PURPOSE: To identify functionally related prognostic gene sets for head and neck squamous cell carcinoma (HNSCC) by unsupervised statistical analysis of microarray data. PATIENTS AND METHODS: Microarray analysis was performed on 14 normal oral epithelium and 71 HNSCCs from patients with outcome data. Spectral clustering (SC) analysis of the data set identified multiple vectors representing distinct aspects of gene expression heterogeneity between samples. Gene ontology (GO) analysis of vector gene lists identified gene sets significantly enriched within defined biologic pathways. The prognostic significance of these was established by Cox survival analysis.
RESULTS: The most influential SC vectors were V2 and V3. V2 separated normal from tumor samples. GO analysis of V2 gene lists identified pathways with heterogeneous expression between HNSCCs, notably focal adhesion (FA)/extracellular matrix remodeling and cytokine-cytokine receptor (CR) interactions. Similar analysis of V3 gene lists identified further heterogeneity in CR pathways. V2CR genes represent an innate immune response, whereas high expression of V3CR genes represented an adaptive immune response that was not dependent on human papillomavirus status. Survival analysis demonstrated that the FA gene set was prognostic of poor outcome, whereas classification for adaptive immune response by the CR gene set was prognostic of good outcome. A combined FA&amp;CR model dramatically exceeded the performance of current clinical classifiers (P < .001 in our cohort and, importantly, P = .007 in an independent cohort of 60 HNSCCs).
CONCLUSION: The application of SC and GO algorithms to HNSCC microarray data identified gene sets highly significant for predicting patient outcome. Further large-scale studies will establish the usefulness of these gene sets in the clinical management of HNSCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20458058     DOI: 10.1200/JCO.2009.24.8724

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  27 in total

Review 1.  The secret ally: immunostimulation by anticancer drugs.

Authors:  Lorenzo Galluzzi; Laura Senovilla; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Rev Drug Discov       Date:  2012-02-03       Impact factor: 84.694

Review 2.  Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.

Authors:  Alexandra Lucs; Benjamin Saltman; Christine H Chung; Bettie M Steinberg; David L Schwartz
Journal:  Head Neck       Date:  2012-01-27       Impact factor: 3.147

Review 3.  New biological markers in the decision of treatment of head and neck cancer patients.

Authors:  A Valenciano; L A Henríquez-Hernández; M Lloret; B Pinar; P C Lara
Journal:  Clin Transl Oncol       Date:  2014-07-01       Impact factor: 3.405

4.  Robust Cell Detection and Segmentation for Image Cytometry Reveal Th17 Cell Heterogeneity.

Authors:  Takahiro Tsujikawa; Guillaume Thibault; Vahid Azimi; Sam Sivagnanam; Grace Banik; Casey Means; Rie Kawashima; Daniel R Clayburgh; Joe W Gray; Lisa M Coussens; Young Hwan Chang
Journal:  Cytometry A       Date:  2019-02-04       Impact factor: 4.355

5.  Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.

Authors:  Adèle Hannigan; Paul Smith; Gabriela Kalna; Cristiana Lo Nigro; Clare Orange; Darren I O'Brien; Reshma Shah; Nelofer Syed; Lindsay C Spender; Blanca Herrera; Johanna K Thurlow; Laura Lattanzio; Martino Monteverde; Meghan E Maurer; Francesca M Buffa; Jelena Mann; David C K Chu; Catharine M L West; Max Patridge; Karin A Oien; Jonathan A Cooper; Margaret C Frame; Adrian L Harris; Louise Hiller; Linda J Nicholson; Milena Gasco; Tim Crook; Gareth J Inman
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

6.  Infiltrating lymphocytes and human papillomavirus-16--associated oropharyngeal cancer.

Authors:  Derrick Wansom; Emily Light; Dafydd Thomas; Francis Worden; Mark Prince; Susan Urba; Douglas Chepeha; Bhavna Kumar; Kitrina Cordell; Avraham Eisbruch; Jeremy Taylor; Jeffrey Moyer; Carol Bradford; Nisha D'Silva; Thomas Carey; Jonathan McHugh; Gregory Wolf
Journal:  Laryngoscope       Date:  2012-01       Impact factor: 3.325

Review 7.  New advances in molecular approaches to head and neck squamous cell carcinoma.

Authors:  Nivedita Sahu; Jennifer Rubin Grandis
Journal:  Anticancer Drugs       Date:  2011-08       Impact factor: 2.248

Review 8.  Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?

Authors:  Luca Tonella; Marco Giannoccaro; Salvatore Alfieri; Silvana Canevari; Loris De Cecco
Journal:  Curr Treat Options Oncol       Date:  2017-05

9.  Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis.

Authors:  Takahiro Tsujikawa; Sushil Kumar; Rohan N Borkar; Vahid Azimi; Guillaume Thibault; Young Hwan Chang; Ariel Balter; Rie Kawashima; Gina Choe; David Sauer; Edward El Rassi; Daniel R Clayburgh; Molly F Kulesz-Martin; Eric R Lutz; Lei Zheng; Elizabeth M Jaffee; Patrick Leyshock; Adam A Margolin; Motomi Mori; Joe W Gray; Paul W Flint; Lisa M Coussens
Journal:  Cell Rep       Date:  2017-04-04       Impact factor: 9.423

10.  A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma.

Authors:  Yi Zhang; Ping Chen; Qiang Zhou; Hongyan Wang; Qingquan Hua; Jie Wang; Hongliang Zhong
Journal:  Front Genet       Date:  2021-06-18       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.